Prediction: Pfizer Will Beat the Market in Five Years
Pfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
Find out which rewards program is best suited for your lifestyle and spending habits. Maximize your value with our expert insights!
22,584 articlesPfizer faced big headwinds after its Covid-era peak, but a longer horizon could open doors for outsized returns. Here...
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Redwire’s backlog and contract wins are lifting the stock, but the company remains unprofitable. This report weighs t...
U.S. lenders are accelerating cash returns to shareholders after stress tests and capital rules ease. JPMorgan, Bank ...
Guild Mortgage is urging FANNIE MAE and FREDDIE MAC to scale residual income analysis, leveraging existing programs t...
Tesla’s AI ambitions are under the microscope as spending climbs and milestones approach. This report analyzes what i...
NASA selects three private partners for a landmark lunar lander push, reshaping the space economy and weighing on mar...
Vanguard has posted a high-level digital assets role, signaling a deeper push into crypto within its vast wealth busi...
Carvana, known for online used-car sales, is making a curious bet on Stellantis. This article explains the rationale,...
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
Joby Aviation stock surging has a few clear triggers: progress on electric air mobility, a strategic partnership with...
A major bank CEO is signaling a bold shift: AI spending could reach trillions. This article explains what that means ...